Nice | Apixaban for the treatment of DVT and PE

27th July 2015 by Louise Hudman

Nice | Apixaban for the treatment of DVT and PE

This is a new guideline from Nice on apixaban. It has now been approved for the treatment of and secondary prevention of DVT and VTE.

Now dabigatran, rivaroxaban and apixaban can all be used in AF, for the prevention of VTE after hip surgery and for treatment and secondary prevention of DVT and PE.

Read more

No bank details needed.

Join free trial

Login

Already a member? Login to view this content.

Login

"I don’t normally do this, but just to say that I thought your article at the front of the latest NASGP magazine about clinical errors was really excellent. Great, and very thoughtful writing. NASGP member."

‘Great, and very thoughtful writing’

‘Great, and very thoughtful writing’

See the full list of features within our NASGP membership plans

Membership